EPSTEIN ROBERT S bought FATE
May 5, 2026 · Form 4 insider transaction
EPSTEIN ROBERT S bought 25,000 shares of Fate Therapeutics, Inc. at $1.69 per share, a transaction worth $42.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$1.69
Total value
$42.3K
InsiderEPSTEIN ROBERT S
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 5, 2026
Filing dateMay 6, 2026
Shares owned after36,331
OwnershipDirect
10b5-1 planNo
AmendedNo